At a glance
ClinicalIndex Comparison RecordN/ACompleted· 72 enrolled
Drug / intervention
Emla-cream +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Emla-Cream as Pain Relief During Pneumococcal Vaccination
In Brief
A clinical study evaluating Emla-cream and Miniderm cream for Children and Pain. Completed, enrolled 72 participants across 1 site.
Detailed Summary
The aim of this intervention study is to compare the efficacy of Emla cream as a pain relief or no pain relief in connection to the first pneumococcal vaccination at the age of three months in Child health care. Primary objective 1.Leads Emla cream as pain relief to children in connection with pneumococcal vaccination at the age of three months to lower pain scores in the use of five items; Face, Legs, Activity, Cry, Consolability (FLACC scale) as a pain measurement instrument?
Study Details
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 2013
Enrollment StartMay 2013
Primary CompletionNov 2015
TodayJul 2026
First PostedMar 1, 2013
Enrollment StartMay 1, 2013
Primary CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 13.3 years ago
Interventions
Emla-creamdrug
Topical anaesthetic
Miniderm creamdrug
Topical